Review article · 2026 · Open access
Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions
Advanced Drug Delivery Reviews, 239, 115982 · Published 28 October 2026 · DOI 10.1016/j.addr.2026.115982
In brief
“Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions” is a 2026 review article by Yeoheung Yun and 6 co-authors, published in Advanced Drug Delivery Reviews. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Advanced Drug Delivery Reviews.
- Citations
- 0
- References
- 243
- Authors
- 7
Abstract
This review examines the emerging role of human brain microphysiological systems (HBMPS) in recapitulating diseases and evaluating their translational potential and limitations for Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE). Both disorders differ in underlying cause, but converge on shared downstream pathophysiology such as tau pathology, neuroinflammation, and blood-brain barrier (BBB) dysfunction. We review the critical pathophysiological features relevant to modeling AD and CTE and introduce HBMPS platforms/validation strategies as potential tools for evaluating therapeutic compounds as well as drug-delivery approaches. We also provide a systematic comparison of the relative advantages and disadvantages of 2D, HBMPS, Xenograft, and animal models and discuss the future potential of HBMPS's drug-testing platform. We further discuss current challenges of HBMPS related to drug testing, engineering extracellular matrix for tissue chips, and BBB penetration in AD and CTE. We suggest future integration of organoid xenografts and AI-assisted frameworks to enhance pathophysiological fidelity/drug predictive capability and to bridge the gap between HBMPS and animal models. In summary, this paper reviews HBMPS technologies as future translation platforms' direction for drug screening and delivery, while providing current limitations and challenges including model validation, reproducibility, and standardized regulatory bases required for preclinical success for HBMPS use. Rather than comparing biological complexity with translational validity, this review applies a decision-oriented framework that distinguishes mechanistic fidelity, comparative candidate ranking, predictive validation, investigational new drug (IND)-supporting use, and replacement of a defined animal test. For each use, we identify quantitative transport, exposure-response, pharmacodynamic, safety, and reproducibility evidence required to support an advance, redesign, or go/stop decision.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Yun, Y., Jena, S., Egido-Betancourt, H., Uzoechi, S., Kim, D. Y., Lee, J.-M., & Nguyen, J. (2026). Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions. Advanced Drug Delivery Reviews, 239, 115982. https://doi.org/10.1016/j.addr.2026.115982
MLA 9
Yun, Yeoheung, et al. “Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions.” Advanced Drug Delivery Reviews, vol. 239, 2026, p. 115982. https://doi.org/10.1016/j.addr.2026.115982.
Chicago
Yun, Yeoheung, Satarupa Jena, Hailey Egido-Betancourt, Samuel Uzoechi, Doo Yeon Kim, Jin-Moo Lee, and Juliane Nguyen. 2026. “Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions.” Advanced Drug Delivery Reviews 239: 115982. https://doi.org/10.1016/j.addr.2026.115982.
Harvard
Yun, Y. et al. (2026) ‘Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions’, Advanced Drug Delivery Reviews, 239, p. 115982. doi:10.1016/j.addr.2026.115982.
IEEE
Y. Yun et al., “Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions,” Advanced Drug Delivery Reviews, vol. 239, p. 115982, 2026, doi: 10.1016/j.addr.2026.115982.
BibTeX
@article{yun2026engineering,
title = {{Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions}},
author = {Yun, Yeoheung and Jena, Satarupa and Egido-Betancourt, Hailey and Uzoechi, Samuel and Kim, Doo Yeon and Lee, Jin-Moo and Nguyen, Juliane},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {239},
pages = {115982},
doi = {10.1016/j.addr.2026.115982},
url = {https://doi.org/10.1016/j.addr.2026.115982}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Alzheimer's disease
- chronic traumatic encephalopathy
- disease modeling
- drug testing
- organoids
- xenografts
- blood-brain barrier
- tau pathology
Work with this paper
Most-cited papers in Engineering
- A Closed‐form Equation for Predicting the Hydraulic Conductivity of Unsaturated SoilsMartinus Th. van Genuchten · Soil Science Society of America Journal · 1980 · 28,197 citations
- An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experimentsW. C. Oliver, George M. Pharr · Journal of materials research/Pratt's guide to venture capital sources · 1992 · 27,379 citations
- Digital communicationsOwen Bishop · Routledge eBooks · 2007 · 24,890 citations
- The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysisNorden Eh Huang, Zhengwei Shen, Steven R. Long and 6 more · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · 1998 · 24,008 citations
- Numerical Heat Transfer and Fluid FlowSuhas V. Patankar · CRC Press eBooks · 2018 · 23,491 citations
Questions about this paper
How do I cite this paper in APA style?
Yun, Y., Jena, S., Egido-Betancourt, H., Uzoechi, S., Kim, D. Y., Lee, J.-M., & Nguyen, J. (2026). Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions. Advanced Drug Delivery Reviews, 239, 115982. https://doi.org/10.1016/j.addr.2026.115982
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Advanced Drug Delivery Reviews: sign in and open the full text from this page.
Who wrote this paper?
Yeoheung Yun, Satarupa Jena, Hailey Egido-Betancourt, Samuel Uzoechi, Doo Yeon Kim, Jin-Moo Lee, Juliane Nguyen.
What is the DOI of this paper?
10.1016/j.addr.2026.115982, permanently at https://doi.org/10.1016/j.addr.2026.115982. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.